Adviser Investments LLC Gilead Sciences, Inc. Transaction History

Adviser Investments LLC

$7.95 Billion
Q3 2024

A detailed history of Adviser Investments LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Adviser Investments LLC holds 32,610 shares of GILD stock, worth $3.02 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

32,610

Previous 31,320 4.12%

Holding current value

$3.02 Million

Previous $2.15 Million 27.23%

% of portfolio

0.03%

Previous 0.03%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$66.59 - $83.99 $85,901 - $108,347	1,290 Added 4.12%	32,610 $2.73 Million
Q2 2024 Aug 12, 2024	SELL	$63.15 - $72.88 $137,351 - $158,514	-2,175 Reduced 6.49%	31,320 $2.15 Million
Q1 2024 Apr 29, 2024	BUY	$71.58 - $87.29 $20,829 - $25,401	291 Added 0.88%	33,495 $2.45 Million
Q4 2023 Feb 01, 2024	BUY	$73.27 - $83.09 $18,317 - $20,772	250 Added 0.76%	33,204 $2.69 Million
Q3 2023 Oct 11, 2023	SELL	$73.94 - $80.67 $23,734 - $25,895	-321 Reduced 0.96%	32,954 $2.47 Million
Q2 2023 Aug 04, 2023	BUY	$76.01 - $86.7 $2.53 Million - $2.88 Million	33,275 New	33,275 $2.56 Million
Q4 2021 Jan 31, 2022	SELL	$64.88 - $73.64 $215,596 - $244,705	-3,323 Closed	0 $0
Q2 2021 Jul 09, 2021	BUY	$63.47 - $69.35 $2,665 - $2,912	42 Added 1.28%	3,323 $229,000
Q1 2021 May 05, 2021	BUY	$60.0 - $68.46 $196,860 - $224,617	3,281 New	3,281 $212,000
Q4 2020 Jan 26, 2021	SELL	$56.65 - $64.55 $189,890 - $216,371	-3,352 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$62.1 - $78.08 $16,953 - $21,315	-273 Reduced 7.53%	3,352 $212,000
Q2 2020 Aug 03, 2020	BUY	$72.34 - $84.0 $262,232 - $304,500	3,625 New	3,625 $279,000
Q3 2018 Nov 14, 2018	SELL	$71.28 - $78.92 $86,533 - $95,808	-1,214 Closed	0 $0
Q2 2018 Aug 02, 2018	SELL	$64.88 - $75.68 $2.97 Million - $3.47 Million	-45,813 Reduced 97.42%	1,214 $86,000
Q1 2018 May 14, 2018	SELL	$72.84 - $88.8 $673,915 - $821,577	-9,252 Reduced 16.44%	47,027 $3.55 Million
Q4 2017 Feb 12, 2018	SELL	$71.15 - $83.52 $747,999 - $878,045	-10,513 Reduced 15.74%	56,279 $4.03 Million
Q3 2017 Oct 23, 2017	BUY	$72.11 - $85.47 $113,284 - $134,273	1,571 Added 2.41%	66,792 $5.41 Million
Q2 2017 Aug 14, 2017	BUY	N/A	65,221	65,221 $4.62 Million

Others Institutions Holding GILD

# of Institutions

1,926

Shares Held

992M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Adviser Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Adviser Investments LLC with notifications on news.

Account

Adviser Investments LLC Gilead Sciences, Inc. Transaction History